May 08, 2025

Naltrexone Forms Show Similar AUD Results

A randomized trial of 248 hospitalized patients with alcohol use disorder found no significant difference in drinking reduction between oral and injectable naltrexone.

Conexiant

May 08, 2025

High Poultry Intake May Be Linked to GI Cancer Mortality

Men who ate over 300 grams of poultry per week had more than double the risk of dying from gastrointestinal cancers, a large Italian study found.

Conexiant

May 06, 2025

Shorter Prostate Radiotherapy Proves Long-Term Match

Two-week radiation treatment for localized prostate cancer delivers equivalent 10-year outcomes to standard 8-week course in a clinical trial.

Conexiant

May 05, 2025

FDA Monthly Round-up: Key April Updates

April’s FDA approvals feature first-in-class therapies, targeted biologics, expanded indications, and innovative delivery systems across allergy, endocrinology, rheumatology, oncology, infectious diseases, and more.

Conexiant

May 02, 2025

Digital Monitoring App Improves Asthma Quality of Life in Trial

A digital asthma symptom monitoring app modestly improved patient-reported quality of life, with greater benefits seen in younger adults and those with low self-management skills.

Conexiant

April 28, 2025

Could a New Urine Test Detect Prostate Cancer? 

Researchers combined spatial transcriptomics with machine learning to develop a urine-based prostate cancer test with 92% accuracy, outperforming traditional PSA testing.

Conexiant

April 28, 2025

Paternal Depression Tied to Child Behavior Study

Paternal depression was associated with 25%–37% higher behavior problem scores, researchers wrote, based on a U.S. cohort study of 1,422 children.

Conexiant

April 25, 2025

Cinnamon Oil May Trigger Drug Interactions

Cinnamaldehyde may modestly activate drug-metabolizing receptors, raising potential herb–drug interaction concerns.

Conexiant

April 24, 2025

Vitamin D Multifaceted CRC Immunomodulator Revealed

"Vitamin D enhances immune organ functions such as the spleen and lymph nodes, and boosts T-cell activity, which is essential in defending the body against tumors."

Conexiant